Eric Siegel
Conseiller Juridique Général chez CARISMA THERAPEUTICS, INC.
Profil
Eric H.
Siegel is currently the Secretary & General Counsel at Carisma Therapeutics, Inc. He previously worked as the Chief Compliance Officer & Deputy General Counsel at Cephalon, Inc. from 2004 to 2007, General Counsel at Solstice Neurosciences, Inc. from 2007 to 2009, Executive Vice President & General Counsel at Incyte Corp.
in 2010-2011, Principal at GSK Plc, and Chief Compliance Officer at EMD Serono, Inc. in 2011.
He also served as the Chief Compliance Officer at Idorsia Pharmaceuticals US, Inc. Mr. Siegel received his graduate degree from the University of Pennsylvania, his MBA from Temple University, and his undergraduate degree from Franklin & Marshall College.
Postes actifs de Eric Siegel
| Sociétés | Poste | Début |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Conseiller Juridique Général | 14/06/2023 |
Anciens postes connus de Eric Siegel
| Sociétés | Poste | Fin |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Compliance Officer | 01/10/2011 |
Solstice Neurosciences, Inc.
 Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | Conseiller Juridique Général | - |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Compliance Officer | - |
| Idorsia Pharmaceuticals US, Inc. | Compliance Officer | - |
| INCYTE CORPORATION | Conseiller Juridique Général | - |
Formation de Eric Siegel
| Temple University (Pennsylvania) | Masters Business Admin |
| Franklin & Marshall College | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GSK PLC | Health Technology |
| INCYTE CORPORATION | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Solstice Neurosciences, Inc.
Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Idorsia Pharmaceuticals US, Inc. |
